Y. Baca

发表

Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer.

A. Deneka, E. Golemis, I. Serebriiskii, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer.

Edward S. Kim, G. Bepler, M. Oberley, 2021, Clinical lung cancer.

Molecular Characterization of Appendiceal Goblet Cell Carcinoid

P. Philip, R. Goldberg, H. Lenz, 2020, Molecular Cancer Therapeutics.

Molecular profile of BRCA-mutated biliary tract cancers

P. Philip, W. El-Deiry, R. Goldberg, 2020, ESMO Open.

Association of Homologous Recombination–DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers

P. Philip, R. Goldberg, H. Lenz, 2021, Molecular Cancer Therapeutics.

Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancer

P. Philip, R. Goldberg, H. Lenz, 2021, Oncogene.

Expression of Immuno-Oncologic Biomarkers Is Enriched in Colorectal Cancers and Other Solid Tumors Harboring the A59T Variant of KRAS

P. Philip, W. El-Deiry, H. Lenz, 2021, Cells.

WRN-Mutated Colorectal Cancer Is Characterized by a Distinct Genetic Phenotype

R. Goldberg, H. Lenz, A. Shields, 2020, Cancers.

Molecular profiles of endometrial cancer tumors among Black patients.

Jubilee Brown, W. Korn, D. Khabele, 2022, Gynecologic oncology.

Genomic profiling in low grade serous ovarian cancer: Identification of novel markers for disease diagnosis and therapy.

Jubilee Brown, T. Herzog, M. Ulm, 2022, Gynecologic oncology.

Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer

Edward S. Kim, M. Socinski, Chul Kim, 2021, Molecular Cancer Therapeutics.

Assessment of immune biomarkers and establishing a triple negative phenotype in gynecologic cancers.

T. Herzog, W. Korn, J. Xiu, 2021, Gynecologic oncology.

Multi-omic characterization reveals a distinct molecular landscape in young-onset pancreatic cancer

H. J. Kim, M. Oberley, S. Maithel, 2022, medRxiv.

Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study.

M. Oberley, H. Lenz, A. Shields, 2023, The Lancet. Oncology.

Distinct genomic landscapes of gastroesophageal adenocarcinoma depending on PD-L1 expression identify mutations in RAS-MAPK pathway and TP53 as potential predictors of immunotherapy efficacy.

M. Oberley, H. Lenz, A. Shields, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

The Landscape of Glycogen Synthase Kinase-3 Beta Genomic Alterations in Cancer

Brittany A. Borden, Lorin Crawford, W. El-Deiry, 2020, Molecular Cancer Therapeutics.

Title: Characterization of KRAS Mutation Subtypes in Non-Small Cell Lung Cancer

Edward S. Kim, M. Socinski, Chul Kim, 2021 .

Correlation of tumor mutational burden (TMB) with CDKN2A and TP53 mutation in HPV-negative head and neck squamous cell carcinoma (HNSCC).

B. Somer, A. Deneka, E. Golemis, 2020 .

Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas.

Chul Kim, J. Nieva, W. Korn, 2021, Journal of Clinical Oncology.

Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer

Z. Trajanoski, R. Goldberg, H. Lenz, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Molecular characterization of appendiceal goblet cell carcinoid.

P. Philip, R. Goldberg, H. Lenz, 2020 .

Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets

R. Goldberg, H. Lenz, A. Shields, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Comprehensive molecular profiling of IDH1/2 mutant biliary cancers (BC).

R. Goldberg, H. Lenz, A. Shields, 2020 .

Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas

Chul Kim, J. Nieva, W. Korn, 2021, Oncotarget.

Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subset

M. Socinski, S. Ou, B. Halmos, 2023, Translational oncology.

PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system

G. Widmann, H. Lenz, A. Shields, 2023, NPJ precision oncology.

Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer

M. Oberley, S. Maithel, D. Kooby, 2023, JCO precision oncology.

Multi-omic characterization reveals a distinct molecular landscape in young-onset pancreatic cancer

M. Oberley, S. Maithel, N. Merchant, 2023, medRxiv.

Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer.

A. Venook, J. Millstein, F. Ou, 2024, European Journal of Cancer.

CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value

Taline Khoukaz, A. Venook, J. Millstein, 2024, Journal for immunotherapy of cancer.

Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC).

Edward S. Kim, M. Socinski, Chul Kim, 2020 .

Comprehensive molecular characterization of brain metastases (BM) from colorectal cancer (CRC)

P. Philip, R. Goldberg, A. Shields, 2019, Annals of Oncology.

Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11-Mutant Non-Small-Cell Lung Cancer.

B. Halmos, H. Borghaei, H. Mamdani, 2024, JCO precision oncology.